Cerebral Microbleeds Are Uncommon in Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages 103-107

  Chatzikonstantinou, Anastasios ^a   Willmann, Olaf ^a   Szabo, Kristina ^a   Hennerici, Michael G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anticoagulation; Ischemic stroke; Microbleeds; Nonvalvular atrial fibrillation; Stroke risk

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN DISEASE; BRAIN ISCHEMIA; CEREBRAL MICROBLEED; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MONITORING; NONVALVULAR ATRIAL FIBRILLATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; RISK FACTOR; SMALL VESSEL DISEASE; STATISTICAL SIGNIFICANCE; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; COMORBIDITY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 79953044474     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00440.x     Document Type: Article

References (38)

1. Imaizumi T, Honma T, Horita Y, et al. Dynamics of dot-like hemosiderin spots on T2*-weighted MRIs associated with stroke recurrence. J Neuroimaging 2007;17:204-210.
2. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637-642.
3. Jeerakathil T, Wolf PA, Beiser A, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35:1831-1835.
4. Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536-1540.
5. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991-994.
6. Tsushima Y, Tanizaki Y, Aoki J, et al. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology 2002;44:31-36.
7. Imaizumi T, Horita Y, Chiba M, et al. Dot-like hemosiderin spots on gradient echo T2*-weighted magnetic resonance imaging are associated with past history of small vessel disease in patients with intracerebral hemorrhage. J Neuroimaging 2004;14:251-257.
8. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165-171.
9. Werring DJ. Cerebral microbleeds: clinical and pathophysiological significance. J Neuroimaging 2007;17:193-203.
10. Andersen LV, Vestergaard P, Deichgraeber P, et al. Warfarin for the prevention of systemic embolism in patients with nonvalvular atrial fibrillation: a meta-analysis. Heart 2008;94:1607-1613.
11. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:429S-456S.
12. Vernooij MW, Haag MD, Van Der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2009;66:714-720.
13. Szabo K, Lanczik O, Hennerici MG. Vascular diagnosis and acute stroke: what, when and why not? Cerebrovasc Dis 2005;20(Suppl 2):11-18.
14. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
15. Adams HPJ, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
16. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke 2006;37:550-555.
17. Fan YH, Zhang L, Lam WW, et al. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003;34:2459-2462.
18. Fan YH, Mok VC, Lam WW, et al. Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts. J Neurol 2004;251:537-541.
19. Werring DJ, Coward LJ, Losseff NA, et al. Cerebral microbleeds are common in ischemic stroke but rare in TIA. Neurology 2005;65:1914-1918.
20. Imaizumi T, Horita Y, Hashimoto Y, et al. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg 2004;101:915-920.
21. Hanyu H, Tanaka Y, Shimizu S, et al. Cerebral microbleeds in Binswanger's disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett 2003;340:213-216.
22. Ovbiagele B, Saver JL, Sanossian N, et al. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients. Cerebrovasc Dis 2006;22:378-383.
23. Chan S, Kartha K, Yoon SS, et al. Multifocal hypointense cerebral lesions on gradient-echo MR are associated with chronic hypertension. AJNR Am J Neuroradiol 1996;17:1821-1827.
24. Boulanger JM, Coutts SB, Eliasziw M, et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke 2006;37:911-914.
25. Naka H, Nomura E, Wakabayashi S, et al. Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. AJNR Am J Neuroradiol 2004;25:714-719.
26. Medi C, Hankey GJ, Freedman SB. Atrial fibrillation. Med J Aust 2007;186:197-202.
27. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
28. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The stroke prevention in atrial fibrillation investigators. Arch Intern Med 1996;156:409-416.
29. Fang MC, Go AS, Hylek EM, et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 2006;54:1231-1236.
30. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005;36:1588-1593.
31. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002;59:193-197.
32. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995;26:1471-1477.
33. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention in Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999;53:1319-1327.
34. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004;141:745-752.
35. Berwaerts J, Webster J. Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. QJM 2000;93:513-521.
36. Hart RG, Benavente O, Pearce LA. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 1999;9:215-217.
37. Rosand J, Hylek EM, O'Donnell HC, et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000;55:947-951.
38. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol 2003;24:88-96.